SU2C has added three new members to our Scientific Advisory Committee (SAC). The addition of these new SAC members will enhance the diversity of expertise and perspectives while complementing and expanding the committee’s capacity to advise on new SU2C research opportunities.

The new SAC members are:

• Scott A. Armstrong, M.D., Ph.D., SVP for drug discovery and chief research strategy officer at Dana-Farber Cancer Institute and David G. Nathan professor of pediatrics at Harvard Medical School
• Suzanne Dahlberg, Ph.D., associate professor of pediatrics at Harvard Medical School and Boston Children’s Hospital
• Tomas J. Philipson, Ph.D., Daniel Levin professor of public policy emeritus at the University of Chicago

Armstrong’s major career focus has been on understanding the biology of pediatric cancers and developing new approaches for treating children with cancer. Specializing in biostatistics, Dahlberg’s work combines designing innovative research studies and tackling statistical issues to improve how medical research is conducted and reported. Philipson’s research focuses on health economics, including the economic aspects of healthcare markets such as personalized medicine, healthcare pricing, and policy analysis.

“SU2C is poised to invest in bold science that will harness the latest technologies to greatly reduce cancer deaths in the coming years and I know that our newest SAC members – alongside the entire committee – will be critical partners as this research unfolds. I’m looking forward to working with Drs. Armstrong, Dahlberg and Philipson and am excited about the expertise they bring to the table in the critical areas of pediatric oncology, biostatistics and healthcare economics.”

– Julian Adams, Ph.D., SU2C president and CEO.

Stand Up To Cancer raises awareness and funds research to detect and treat cancers with the aspiration to cure all patients.